Lawrence Livermore concept for a self-contained thorium reactor. Called SSTAR
(small, sealed, transportable, autonomous reactor), it will produce up to 100 MW
and can be safely transported by ship or heavy truck.
 

Intellectual Ventures

By Malcolm Gladwell
The New Yorker, May 12, 2008

Edited by Andy Ross

Nathan Myhrvold looks every bit the bearded, fair-haired Viking. He is gregarious, enthusiastic, and nerdy on an epic scale. He graduated from high school at fourteen. He started Microsoft's research division, leaving, in 1999, with hundreds of millions. He is obsessed with aperiodic tile patterns.

In 1999, when Nathan Myhrvold left Microsoft and struck out on his own, he set himself an unusual goal. He wanted to see whether the kind of insight that leads to invention could be engineered. He formed a company called Intellectual Ventures. He wanted to make insights — to come up with ideas, patent them, and then license them to interested companies.

One rainy day last November, Myhrvold held an "invention session," as he calls such meetings, on the technology of self-assembly. What if it was possible to break a complex piece of machinery into a thousand pieces and then have the machine put itself back together again? That had to be useful. But for what?

The meeting, like many of Myhrvold's sessions, was held in a conference room in the Intellectual Ventures laboratory, a big warehouse in an industrial park across Lake Washington from Seattle: plasma TV screens on the walls, a long table furnished with bottles of Diet Pepsi and big bowls of cashews.

Chairing the meeting was Casey Tegreene, an electrical engineer with a law degree, who is the chief patent counsel for I.V. He stood at one end of the table. Myhrvold was at the opposite end. Next to him was Edward Jung, whom Myhrvold met at Microsoft. Jung is lean and sleek, with closely cropped fine black hair. On the other side of the table from Jung was Lowell Wood, an imposing man with graying red hair and an enormous head.

Myhrvold says, "Lowell was the great protégé of Edward Teller. He was at Lawrence Livermore. He was the technical director of Star Wars." Myhrvold and Wood have known each other since Myhrvold was a teenager and Wood interviewed him for a graduate fellowship called the Hertz. Wood bent the rules for Myhrvold. The Hertz was supposed to be for research in real-world problems, but Myhrvold's field at that point was quantum cosmology.

The chairman of the chemistry department at Stanford, Richard Zare, had flown in for the day, as had Eric Leuthardt, a young neurosurgeon from Washington University, in St. Louis, who is a regular at I.V. sessions. At the back was a sombre, bearded man named Rod Hyde, who had been Wood's protégé at Lawrence Livermore.

Tegreene started in on the "prep." In the previous weeks, he and his staff had reviewed the relevant scientific literature and recent patent filings in order to come up with a short briefing on what was and wasn't known about self-assembly. A short BBC documentary was shown, on the early work of the scientist Lionel Penrose. Richard Zare passed around a set of what looked like ceramic dice. Leuthardt drew elaborate diagrams on the blackboard. Self-assembly was very useful in cases where you had to get something very large through a very small hole — and Leuthardt wondered if it might be helpful in minimally invasive surgery.

Before long, self-assembly was put aside and the talk swung to how to improve X-rays, and then to the puzzling phenomenon of soldiers in Iraq who survive a bomb blast only to die a few days later of a stroke. Wood thought it was a shock wave, penetrating the soldiers' helmets and surging through their brains, tearing blood vessels away from tissue. "Lowell is the living example of something better than the Internet," Jung said after the meeting was over. "On the Internet, you can search for whatever you want, but you have to know the right terms. With Lowell, you just give him a concept, and this stuff pops out."

In August of 2003, I.V. held its first invention session, and it was a revelation. "Afterward, Nathan kept saying, ‘There are so many inventions,' " Wood recalled. "He thought if we came up with a half-dozen good ideas it would be great, and we came up with somewhere between fifty and a hundred. I said to him, ‘But you had eight people in that room who are seasoned inventors. Weren't you expecting a multiplier effect?' And he said, ‘Yeah, but it was more than multiplicity.' Not even Nathan had any idea of what it was going to be like."

The original expectation was that I.V. would file a hundred patents a year. Currently, it's filing five hundred a year. It has a backlog of three thousand ideas. Wood said that he once attended a two-day invention session presided over by Jung, and after the first day the group went out to dinner. "So Edward took his people out, plus me," Wood said. "And the eight of us sat down at a table and the attorney said, ‘Do you mind if I record the evening?' And we all said no, of course not. We sat there. It was a long dinner. I thought we were lightly chewing the rag. But the next day the attorney comes up with eight single-spaced pages flagging 36 different inventions from dinner."

And the kinds of ideas the group came up with weren't trivial. Intellectual Ventures just had a patent issued on automatic, battery-powered glasses, with a tiny video camera that reads the image off the retina and adjusts the fluid-filled lenses accordingly, up to ten times a second. It just licensed off a cluster of its patents, for 80 million dollars. It has invented new kinds of techniques for making microchips and improving jet engines; it has proposed a way to custom-tailor the mesh "sleeve" that neurosurgeons can use to repair aneurysms.

Bill Gates, whose company, Microsoft, is one of the major investors in Intellectual Ventures, says, "I can give you fifty examples of ideas they've had where, if you take just one of them, you'd have a startup company right there." Gates has participated in a number of invention sessions, and, with other members of the Gates Foundation, meets every few months with Myhrvold to brainstorm about things like malaria or H.I.V. "Nathan sent over a hundred scientific papers beforehand," Gates said of the last such meeting. "The amount of reading was huge. But it was fantastic."

One of the sessions that Gates participated in was on the possibility of resuscitating nuclear energy. "Teller had this idea way back when that you could make a very safe, passive nuclear reactor," Myhrvold explained. "No moving parts. Proliferation-resistant. Dead simple. Every serious nuclear accident involves operator error, so you want to eliminate the operator altogether. Lowell and Rod and others wrote a paper on it once. So we did several sessions on it."

The plant, as they conceived it, would produce one to three gigawatts of power. The reactor core would be enclosed in a sealed, armored box. The box would work for thirty years, without need for refuelling. Wood's idea was that the box would run on thorium, which is a very common, mildly radioactive metal. Myhrvold's idea was that it should run on spent fuel from existing power plants. "Waste has negative cost," Myhrvold said. "This is how we make this idea politically and regulatorily attractive. Lowell and I had a monthlong no-holds-barred nuclear-physics battle. He didn't believe waste would work. It turns out it does." Myhrvold grinned. "He concedes it now."

It was a long-shot idea, easily fifteen years from reality, if it became a reality at all. It was just a tantalizing idea at this point, but who wasn't interested in seeing where it would lead? "We have thirty guys working on it," he went on. "I have more people doing cutting-edge nuclear work than General Electric. We're looking for someone to partner with us, because this is a huge undertaking."

Last March, Myhrvold decided to do an invention session with Eric Leuthardt and several other physicians in St. Louis. Rod Hyde came, along with a scientist from M.I.T. named Ed Boyden. Wood was there as well.

"Lowell came in looking like the Cheshire Cat," Myhrvold recalled. "He said, ‘I have a question for everyone. You have a tumor, and the tumor becomes metastatic, and it sheds metastatic cancer cells. How long do those circulate in the bloodstream before they land?' And we all said, ‘We don't know. Ten times?' ‘No,' he said. ‘As many as a million times.' Isn't that amazing? If you had no time, you'd be screwed. But it turns out that these cells are in your blood for as long as a year before they land somewhere. What that says is that you've got a chance to intercept them."

Wood did some arithmetic. He knew that human beings have only about five litres of blood. He knew that the heart pumps close to a hundred millilitres of blood per beat, which means that all of our blood circulates through our bloodstream in a matter of minutes.

"It turns out that some small per cent of tumor cells are actually the deadly ones," he went on. "Tumor stem cells are what really initiate metastases. And isn't it astonishing that they have to turn over at least ten thousand times before they can find a happy home? You naïvely think it's once or twice or three times. Maybe five times at most. It isn't. In other words, metastatic cancer — the brand of cancer that kills us — is an amazingly hard thing to initiate. Which strongly suggests that if you tip things just a little bit you essentially turn off the process."

That was the idea that Wood presented to the room in St. Louis. From there, the discussion raced ahead. Myhrvold and his inventors had already done a lot of thinking about using tiny optical filters capable of identifying and zapping microscopic particles. They also knew that finding cancer cells in blood is not hard. They're often the wrong size or the wrong shape. So what if you slid a tiny filter into a blood vessel of a cancer patient? "You don't have to intercept very much of the blood for it to work," Wood went on. "Maybe one ten-thousandth of it. The filter could be put in a little tiny vein in the back of the hand, because that's all you need. Or maybe I intercept all of the blood, but then it doesn't have to be a particularly efficient filter."

Wood was a physicist, not a doctor, but that wasn't necessarily a liability, at this stage. "People in biology and medicine don't do arithmetic," he said. He wasn't being critical of biologists and physicians: this was, after all, a man who read medical journals for fun. At that moment, while reading The New England Journal, Wood had the advantages of someone looking at a familiar fact with a fresh perspective.

That was also why Myhrvold had wanted to take his crew to St. Louis to meet with the surgeons. Surgeons had all kinds of problems that they didn't realize had solutions, and physicists had all kinds of solutions to things that they didn't realize were problems. At one point, Myhrvold asked the surgeons what, in a perfect world, would make their lives easier, and they said that they wanted an X-ray that went only skin deep. They wanted to know, before they made their first incision, what was just below the surface. When the Intellectual Ventures crew heard that, their response was amazement. "That's your dream? A subcutaneous X-ray? We can do that."

Insight could be orchestrated: that was the lesson. If someone who knew how to make a filter had a conversation with someone who knew a lot about cancer and with someone who read the medical literature like a physicist, then maybe you could come up with a cancer treatment. It helped as well that Casey Tegreene had a law degree, Lowell Wood had spent his career dreaming up weapons for the government, Nathan Myhrvold was a ball of fire. They had different backgrounds and temperaments and perspectives, and if you gave them something to think about that they did not ordinarily think about you were guaranteed a fresh set of eyes.

There were drawbacks to this approach, of course. They would make a lot of mistakes and chase down a lot of rabbit holes. Myhrvold admits that many of the ideas that come out of the invention sessions come to naught. After a session, the Ph.D.s on the I.V. staff examine each proposal closely and decide which ones are worth pursuing. After I.V. came up with its cancer-filter idea, it discovered that there was a company, based in Rochester, that was already developing a cancer filter. But so what? Myhrvold had plenty of other ideas to pursue.
 

Nathan Myhrvold is the founder and CEO of Intellectual Ventures. During his 14-year tenure at Microsoft, he was responsible for founding Microsoft Research and numerous technology groups that resulted in many of Microsoft's most successful products. Earlier, he was a postdoctoral fellow at Cambridge University and worked with Stephen Hawking on research in cosmology, quantum field theory in curved space time and quantum theories of gravitation. Myhrvold earned a doctorate in theoretical and mathematical physics and a master's degree in mathematical economics from Princeton University.
 

AR  Why am I hanging around here when I could be dreaming big dreams with Nathan in Seattle?